The Czech Office for the Protection of Competition (the “Office”) imposed by its first-instance decision a fine in the aggregate amount of cca 113 million CZK (cca 4 million EUR) on a group of four largest distributors of pharmaceuticals in the Czech Republic. The
The Czech Competition Office imposes a fine on pharmaceuticals distributors for coordinating suspension of their supplies to public Czech hospitals (Alliance UniChem, Gehe Pharma Praha, Pharmos, Phoenix)
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.